MolvirTM

Molnupiravir
Influenza Antiviral (Systemic Antiviral)

Indication:

Indicated for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness.

Dosage & Administration:

The recommended dose is 800 mg (four 200 mg capsules) taken orally every 12 hours for 5 days

Preparation:

Each box contains 10 capsules in blister pack.